— Know what they know.
Not Investment Advice

PBSV OTC

Pharma-Bio Serv, Inc.
1W: +13.6% 1M: -7.4% 3M: -12.3% YTD: -4.5% 1Y: -25.4% 3Y: -40.2% 5Y: -12.6%
$0.50
+0.05 (+11.11%)
 
Weekly Expected Move ±24.4%
$0 $0 $0 $1 $1
OTC · Industrials · Specialty Business Services · Tech Score Neutral · Power 61 · $11.5M mcap · 8M float · 0.0060% daily turnover · Short 64% of daily vol
Smart Money Score
No convergence signal
Key Statistics
Market Cap$11.5M
52W Range0.32-1.36
Volume51,860
Avg Volume487
Beta0.75
Dividend$0.07
Analyst Ratings
No analyst coverage
Company Info
CEOVictor Sanchez
Employees55
SectorIndustrials
IndustrySpecialty Business Services
IPO Date2007-05-07
Pharma-Bio Serv Building, #6 Road 696
Dorado, PR 00646
PR
787 278 2709
About Pharma-Bio Serv, Inc.

Pharma-Bio Serv, Inc. functions as a specialized consulting firm, providing services focused on regulatory compliance and the transfer of technology. The company offers its compliance expertise to a diverse range of clients, including those in the pharmaceutical, chemical, biotechnology, medical device, cosmetic, and food industries, as well as related product companies. Its operational reach extends across Puerto Rico, the United States, Europe, and Brazil. The firm's technical advisory offerings encompass vital areas such as regulatory adherence, system validation, technology migration, engineering solutions, comprehensive project management, and ongoing process support. Established in 1993, Pharma-Bio Serv maintains its corporate headquarters in Dorado, Puerto Rico.

Recent Insider Trades

NameTypeSharesPriceDate
SPINDEL HOWARD J-Other 42,504 — 2026-06-09
MICHEL KIRK WHEELER A-Award 20,000 $0.54 2026-01-10
Perlysky Dov A-Award 20,000 $0.54 2026-01-10
SPINDEL HOWARD A-Award 20,000 $0.54 2026-01-10
WIESEN IRVING L A-Award 20,000 $0.54 2026-01-10

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms